|Bid||24.58 x 1200|
|Ask||24.57 x 900|
|Day's Range||23.74 - 25.45|
|52 Week Range||9.25 - 28.66|
|Beta (5Y Monthly)||1.56|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Puma Biotech (PBYI) beats first-quarter estimates for both earnings and sales. Stock up.
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you want to know who really controls Prothena Corporation plc ( NASDAQ:PRTA ), then you'll have to look at the...